Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001250853-10-000100)

Filing Details

Accession Number:: 0001250853-10-000100
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-30 16:29:08
Reporting Period:: 2010-12-29

Filing Date:: 2010-12-30
Accepted Time:: 2010-12-30 16:29:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1390478	Rxi Pharmaceuticals Corp	RXII	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
799698	Cytrx Corp	11726 San Vicente Boulevard Suite 650 Los Angeles CA 90049		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-12-29	2,593,881	$2.20	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.